Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 1—January 2005

SARS Clinical Features, United States, 2003

Padmini Srikantiah*1, Myrna D. Charles*, Sarah Reagan*, Thomas A. Clark*, Mathias W.R. Pletz*, Priti R. Patel*, Robert M. Hoekstra*, Jairam Lingappa*2, John A. Jernigan*, Marc Fischer*Comments to Author , and for the CDC SARS Clinical Investigation Team
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 2

Clinical, radiographic, and laboratory features of patients with laboratory-confirmed SARS-CoV infection, United States, 2003 (N = 8)*†

Finding n (%)
Radiographic findings
  Abnormal chest radiograph 8 (100)
  Bilateral infiltrates 7 (88)
  Prolonged progression of infiltrates‡ 6 (75)
  Pleural effusions 3 (38)
  Acute respiratory distress syndrome 1 (13)
Laboratory findings
  Hematocrit <36% 2 (25)
  Leukocyte count <4,000 cells/mm3 2 (25)
  Absolute lymphocyte count <1,500 cells/mm3 7 (88)
  Platelets <150,000/mm3 2 (25)
Clinical course and outcomes
  Hospitalized 7 (88)
  Admitted to intensive care unit 2 (25)
  Received supplemental oxygen 6 (75)
  Required mechanical ventilation 1 (13)
  Died 0 (0)

*Features present at any time during course of illness.
†SARS-CoV, severe acute respiratory syndrome–associated coronavirus.
‡Radiographic worsening of infiltrates >7 days after onset of symptoms.

Main Article

1Dr. Srikantiah is currently a fellow in the Division of Infectious Diseases at the University of California San Francisco.

2Dr. Lingappa is an assistant professor in the Department of Medicine at the University of Washington.

3The CDC SARS Clinical Investigation Team included Akinyi Adija, Bernadette Albanese, Cindy Allard, Felicia Alvarez, Fermin Arguello, Gregory Armstrong, Christine Barton, Geoff Beckett, William Bellini, Megan Davies, Paul Drummond, Dean Erdman, Leigh Farrington, Dara Friedman, Ken Gershman, Jayne Griffith, Kevin Griffith, Heath Harmon, Rita Helfand, Jo Hoffman, Gregory Huhn, Daniel Jernigan, Geraldine Johnson, Paul Kitsutani, Thomas Ksiazek, Ashley LaMonte, Bhrett Lash, Kathryn Lofy, Ruth Lynfield, Joseph Malone, Bela Matyas, Clifford McDonald, Marty Monroe, Steven Monroe, Pat Mshar, Maureen Murphy, Michelle Packard, Neil Pascoe, Michael Phillips, James Rankin, Chesley Richards, Corey Robertson, Peggy Robinson-Dixon, Marc Romney, Maria Pia Sanchez, David Shay, Chad Smelser, David Stephens, Shelley Stonecipher, Tina Tan, Sharon Thompson, J. Todd Weber, and Cindy Weinbaum.

Page created: April 14, 2011
Page updated: April 14, 2011
Page reviewed: April 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.